
- Pharmaceutical Executive: July 2023
- Volume 43
- Issue 7
Marketing in the AI Age
Here in New Jersey, our home base, summer is officially upon us, and the Canadian wildfire smoke has just cleared from the air. I’m sure the bird watchers would attest to the eager chirping as both wildlife and humans greedily enjoy the beautiful weather. But even as the seasons change, so does the technology that drives innovation, as coverage in the July issue of Pharmaceutical Executive® attests.
In a special
- Harnessing the power of AI to bolster your own marketing technology strategies
- Intellectual property and content creation
- Legislation coming down the pipeline for AI
- Ethical concerns, privacy, and data security for AI, especially as it relates to pharma marketing
- AI and pharmacy marketing
We also hear from Doron Aspitz, CEO, Verix, on AI—specifically
I predict AI will be on the tips of everyone’s tongues in pharma—and outside of it—for some time yet.
In this month’s
In yet another important discussion, Mike Hollan, editor,
As ever, a huge thank you to all of the writers and experts who contributed to this issue and shared their advice and expertise. And thank you, dear reader, for tuning into another issue of Pharm Exec. There are loads of great content that you won’t want to miss.
Articles in this issue
over 2 years ago
Crossing the Brain Barrierover 2 years ago
Biotech’s Survival Story: Companies Bear Down for Lean Yearsover 2 years ago
Harnessing AI for Pharma Salesover 2 years ago
Tapping New and Improved Drug Innovations in Asiaover 2 years ago
Drug Shortages Continue to Plague FDA, Manufacturersover 2 years ago
Contrasting Aims Highlight Pharma Reform Pursuitsover 2 years ago
Shifting Macro Trends Offer Hope for Biotech Performance BoostNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.